---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-157328"
form_type: "8-K"
ticker: "ALDX"
cik: "0001341235"
company_name: "Aldeyra Therapeutics, Inc."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:30:14.538963+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Aldeyra annual meeting results: directors elected, auditor ratified, say-on-pay approved

## Summary
- Directors Nancy B. Miller-Rich (21.9M for, 12.6M withheld) and Ben R. Bronstein (22.7M for, 11.8M withheld) elected as Class I directors.
- Shareholders ratified BDO USA as independent auditor for FY 2024: 44.1M for, 372.8K against, 186.6K abstain.
- Non-binding advisory vote on named executive officer compensation approved: 31.5M for, 2.9M against, 126.6K abstain, 10.2M broker non-votes.
- Total shares voted: 44,659,863 of 59,414,489 eligible (75.2% quorum).

## SEC filing metadata
- accession: 0001193125-24-157328
- form_type: 8-K
- ticker: ALDX
- cik: 0001341235
- company_name: Aldeyra Therapeutics, Inc.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1341235/000119312524157328/0001193125-24-157328-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1341235/000119312524157328/d843373d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-157328
- JSON: https://secwatch.observer/filing/0001193125-24-157328.json
- Plain text: https://secwatch.observer/filing/0001193125-24-157328.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.